Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

Brenda K. Edwards, Martin L. Brown, Phyllis A. Wingo, Holly L. Howe, Elizabeth Ward, Lynn A.G. Ries, Deborah Schrag, Patricia M. Jamison, Ahmedin Jemal, Xiao Cheng Wu, Carol Friedman, Linda Harlan, Joan Warren, Robert N. Anderson, Linda W. Pickle

Research output: Contribution to journalReview article

798 Citations (Scopus)

Abstract

Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide information on cancer rates and trends in the United States. This year's report updates statistics on the 15 most common cancers in the five major racial/ethnic populations in the United States for 1992-2002 and features population-based trends in cancer treatment. Methods: The NCI, the CDC, and the NAACCR provided in formation on cancer cases, and the CDC provided information on cancer deaths. Reported incidence and death rates were age-adjusted to the 2000 U.S. standard population, annual percent change in rates for fixed intervals was estimated by linear regression, and annual percent change in trends was estimated with joinpoint regression analysis. Population-based treatment data were derived from the Surveillance, Epidemiology, and End Results (SEER) Program registries, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Results: Among men, the incidence rates for all cancer sites combined were stable from 1995 through 2002. Among women, the incidence rates increased by 0.3% annually from 1987 through 2002. Death rates in men and women combined decreased by 1.1% annually from 1993 through 2002 for all cancer sites combined and also for many of the 15 most common cancers. Among women, lung cancer death rates increased from 1995 through 2002, but lung cancer incidence rates stabilized from 1998 through 2002. Although results of cancer treatment studies suggest that much of contemporary cancer treatment for selected cancers is consistent with evidence-based guidelines, they also point to geographic, racial, economic, and age-related disparities in cancer treatment. Conclusions: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations. Data from population-based cancer registries, supplemented by linkage with administrative databases, are an important resource for monitoring the quality of cancer treatment. Use of this cancer surveillance system, along with new developments in medical informatics and electronic medical records, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention, detection, and uniformly high quality of care in all areas and populations of the United States.

Original languageEnglish (US)
Pages (from-to)1407-1427
Number of pages21
JournalJournal of the National Cancer Institute
Volume97
Issue number19
DOIs
StatePublished - Oct 1 2005

Fingerprint

Annual Reports
Population
Neoplasms
Therapeutics
Registries
National Cancer Institute (U.S.)
Centers for Disease Control and Prevention (U.S.)
Mortality
Quality of Health Care
Incidence
Lung Neoplasms
Medical Electronics
Databases
SEER Program
Guidelines

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., ... Pickle, L. W. (2005). Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Journal of the National Cancer Institute, 97(19), 1407-1427. https://doi.org/10.1093/jnci/dji289
Edwards, Brenda K. ; Brown, Martin L. ; Wingo, Phyllis A. ; Howe, Holly L. ; Ward, Elizabeth ; Ries, Lynn A.G. ; Schrag, Deborah ; Jamison, Patricia M. ; Jemal, Ahmedin ; Wu, Xiao Cheng ; Friedman, Carol ; Harlan, Linda ; Warren, Joan ; Anderson, Robert N. ; Pickle, Linda W. / Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. In: Journal of the National Cancer Institute. 2005 ; Vol. 97, No. 19. pp. 1407-1427.
@article{464df6eda2314910aa4d9368b151c778,
title = "Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment",
abstract = "Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide information on cancer rates and trends in the United States. This year's report updates statistics on the 15 most common cancers in the five major racial/ethnic populations in the United States for 1992-2002 and features population-based trends in cancer treatment. Methods: The NCI, the CDC, and the NAACCR provided in formation on cancer cases, and the CDC provided information on cancer deaths. Reported incidence and death rates were age-adjusted to the 2000 U.S. standard population, annual percent change in rates for fixed intervals was estimated by linear regression, and annual percent change in trends was estimated with joinpoint regression analysis. Population-based treatment data were derived from the Surveillance, Epidemiology, and End Results (SEER) Program registries, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Results: Among men, the incidence rates for all cancer sites combined were stable from 1995 through 2002. Among women, the incidence rates increased by 0.3{\%} annually from 1987 through 2002. Death rates in men and women combined decreased by 1.1{\%} annually from 1993 through 2002 for all cancer sites combined and also for many of the 15 most common cancers. Among women, lung cancer death rates increased from 1995 through 2002, but lung cancer incidence rates stabilized from 1998 through 2002. Although results of cancer treatment studies suggest that much of contemporary cancer treatment for selected cancers is consistent with evidence-based guidelines, they also point to geographic, racial, economic, and age-related disparities in cancer treatment. Conclusions: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations. Data from population-based cancer registries, supplemented by linkage with administrative databases, are an important resource for monitoring the quality of cancer treatment. Use of this cancer surveillance system, along with new developments in medical informatics and electronic medical records, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention, detection, and uniformly high quality of care in all areas and populations of the United States.",
author = "Edwards, {Brenda K.} and Brown, {Martin L.} and Wingo, {Phyllis A.} and Howe, {Holly L.} and Elizabeth Ward and Ries, {Lynn A.G.} and Deborah Schrag and Jamison, {Patricia M.} and Ahmedin Jemal and Wu, {Xiao Cheng} and Carol Friedman and Linda Harlan and Joan Warren and Anderson, {Robert N.} and Pickle, {Linda W.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1093/jnci/dji289",
language = "English (US)",
volume = "97",
pages = "1407--1427",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "19",

}

Edwards, BK, Brown, ML, Wingo, PA, Howe, HL, Ward, E, Ries, LAG, Schrag, D, Jamison, PM, Jemal, A, Wu, XC, Friedman, C, Harlan, L, Warren, J, Anderson, RN & Pickle, LW 2005, 'Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment', Journal of the National Cancer Institute, vol. 97, no. 19, pp. 1407-1427. https://doi.org/10.1093/jnci/dji289

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. / Edwards, Brenda K.; Brown, Martin L.; Wingo, Phyllis A.; Howe, Holly L.; Ward, Elizabeth; Ries, Lynn A.G.; Schrag, Deborah; Jamison, Patricia M.; Jemal, Ahmedin; Wu, Xiao Cheng; Friedman, Carol; Harlan, Linda; Warren, Joan; Anderson, Robert N.; Pickle, Linda W.

In: Journal of the National Cancer Institute, Vol. 97, No. 19, 01.10.2005, p. 1407-1427.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

AU - Edwards, Brenda K.

AU - Brown, Martin L.

AU - Wingo, Phyllis A.

AU - Howe, Holly L.

AU - Ward, Elizabeth

AU - Ries, Lynn A.G.

AU - Schrag, Deborah

AU - Jamison, Patricia M.

AU - Jemal, Ahmedin

AU - Wu, Xiao Cheng

AU - Friedman, Carol

AU - Harlan, Linda

AU - Warren, Joan

AU - Anderson, Robert N.

AU - Pickle, Linda W.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide information on cancer rates and trends in the United States. This year's report updates statistics on the 15 most common cancers in the five major racial/ethnic populations in the United States for 1992-2002 and features population-based trends in cancer treatment. Methods: The NCI, the CDC, and the NAACCR provided in formation on cancer cases, and the CDC provided information on cancer deaths. Reported incidence and death rates were age-adjusted to the 2000 U.S. standard population, annual percent change in rates for fixed intervals was estimated by linear regression, and annual percent change in trends was estimated with joinpoint regression analysis. Population-based treatment data were derived from the Surveillance, Epidemiology, and End Results (SEER) Program registries, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Results: Among men, the incidence rates for all cancer sites combined were stable from 1995 through 2002. Among women, the incidence rates increased by 0.3% annually from 1987 through 2002. Death rates in men and women combined decreased by 1.1% annually from 1993 through 2002 for all cancer sites combined and also for many of the 15 most common cancers. Among women, lung cancer death rates increased from 1995 through 2002, but lung cancer incidence rates stabilized from 1998 through 2002. Although results of cancer treatment studies suggest that much of contemporary cancer treatment for selected cancers is consistent with evidence-based guidelines, they also point to geographic, racial, economic, and age-related disparities in cancer treatment. Conclusions: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations. Data from population-based cancer registries, supplemented by linkage with administrative databases, are an important resource for monitoring the quality of cancer treatment. Use of this cancer surveillance system, along with new developments in medical informatics and electronic medical records, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention, detection, and uniformly high quality of care in all areas and populations of the United States.

AB - Background: The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide information on cancer rates and trends in the United States. This year's report updates statistics on the 15 most common cancers in the five major racial/ethnic populations in the United States for 1992-2002 and features population-based trends in cancer treatment. Methods: The NCI, the CDC, and the NAACCR provided in formation on cancer cases, and the CDC provided information on cancer deaths. Reported incidence and death rates were age-adjusted to the 2000 U.S. standard population, annual percent change in rates for fixed intervals was estimated by linear regression, and annual percent change in trends was estimated with joinpoint regression analysis. Population-based treatment data were derived from the Surveillance, Epidemiology, and End Results (SEER) Program registries, SEER-Medicare linked databases, and NCI Patterns of Care/Quality of Care studies. Results: Among men, the incidence rates for all cancer sites combined were stable from 1995 through 2002. Among women, the incidence rates increased by 0.3% annually from 1987 through 2002. Death rates in men and women combined decreased by 1.1% annually from 1993 through 2002 for all cancer sites combined and also for many of the 15 most common cancers. Among women, lung cancer death rates increased from 1995 through 2002, but lung cancer incidence rates stabilized from 1998 through 2002. Although results of cancer treatment studies suggest that much of contemporary cancer treatment for selected cancers is consistent with evidence-based guidelines, they also point to geographic, racial, economic, and age-related disparities in cancer treatment. Conclusions: Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations. Data from population-based cancer registries, supplemented by linkage with administrative databases, are an important resource for monitoring the quality of cancer treatment. Use of this cancer surveillance system, along with new developments in medical informatics and electronic medical records, may facilitate monitoring of the translation of basic science and clinical advances to cancer prevention, detection, and uniformly high quality of care in all areas and populations of the United States.

UR - http://www.scopus.com/inward/record.url?scp=26944473246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944473246&partnerID=8YFLogxK

U2 - 10.1093/jnci/dji289

DO - 10.1093/jnci/dji289

M3 - Review article

C2 - 16204691

AN - SCOPUS:26944473246

VL - 97

SP - 1407

EP - 1427

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 19

ER -